Study Stopped
Study withdrawn following PI departure from Sponsor institution.
Timing of Bridge Plate Removal and Distal Radius Fracture Outcomes
TORPEDO
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this randomized control trial will be to determine whether the duration of bridge plate fixation of distal radius fractures can be reduced to 6-8 weeks without worsening of functional outcomes relative to the current standard of greater than 12 weeks of fixation. The secondary aim of the study is to determine whether a reduced duration of bridge plate fixation leads to an increase in wrist range of motion following plate removal compared to the standard duration of fixation. 100 patients with comminuted distal radius fractures that are indicated for bridge plate fixation will be randomized to the Accelerated Removal arm (n = 50) or the Standard Removal arm (n = 50).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2022
CompletedFirst Posted
Study publicly available on registry
October 13, 2022
CompletedStudy Start
First participant enrolled
January 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedDecember 24, 2024
December 1, 2024
3 years
October 11, 2022
December 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Disabilities of the Arm, Shoulder, and Hand (DASH) Score
30-item questionnaire that asks the patient to rate their difficulty with common functional tasks and the severity of upper extremity symptoms over the past week. DASH is reported on a scale of 0-100 with lower scores indicating less severe symptoms and superior function. A decrease in scores indicates symptoms became less severe and function improved during the observational period.
Baseline, Week 104
Secondary Outcomes (12)
Change in Patient-Related Wrist Evaluation (PRWE) Questionnaire Score
Baseline, Week 104
Change in Volar Tilt
Removal of Bridge Plate (from Week 6 to up to Week 14), Week 104
Change in Radial Inclination
Removal of Bridge Plate (from Week 6 to up to Week 14), Week 104
Change in Radial Height
Removal of Bridge Plate (from Week 6 to up to Week 14), Week 104
Change in Ulnar Variance
Removal of Bridge Plate (from Week 6 to up to Week 14), Week 104
- +7 more secondary outcomes
Study Arms (2)
Bridge Plate Removal at 6-8 Weeks Postoperatively
EXPERIMENTALParticipants will undergo dorsal spanning bridge plate fixation per standard technique. Patients in the experimental group will return to the operative room for removal of the bridge plate at Week 6-8. Patients will begin the standardized postoperative rehabilitation protocol immediately following bridge plate removal on Week 6-8.
Bridge Plate Removal at 12-14 Weeks Postoperatively
ACTIVE COMPARATORParticipants will undergo dorsal spanning bridge plate fixation per standard technique. Patients in the control group will return to the operating room for removal of the bridge plate at Week 12-14. Patients will begin the standardized postoperative rehabilitation protocol immediately following bridge plate removal on Week 12-14.
Interventions
Dorsal spanning bridge fixation will be performed by board-certified orthopedic surgeons per standard technique.
Dorsal spanning bridge removal will be performed by board-certified orthopedic surgeons per standard technique.
Eligibility Criteria
You may qualify if:
- Fracture of the distal radius indicated for operative treatment using bridge plate fixation
- Age 18 years or greater
- Capacity to provide informed consent
You may not qualify if:
- Bridge plate fixation in the setting of revision surgery for prior nonunion or malunion
- Bilateral distal radius fractures (prevents accurate measurement of postoperative range of motion and strength of the injured extremity without a normal contralateral extremity for comparison)
- Pathologic fractures
- Patients that will be unable to complete the necessary follow up, including incarcerated patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NYU Langone Health
New York, New York, 11215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali Azad, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2022
First Posted
October 13, 2022
Study Start
January 5, 2023
Primary Completion
January 1, 2026
Study Completion (Estimated)
January 1, 2028
Last Updated
December 24, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Ali.Azad@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: Ali.Azad@nyulangone.org. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.